Challenges and opportunities in computational studies for lipid nanoparticle development

Lipid nanoparticles (LNPs) are essential carriers for genetic medicines, yet optimizing their design remains challenging due to numerous parameters. Computational methods—including molecular dynamics (MD), computational fluid dynamics (CFD), and machine learning (ML)—offer molecular insights and predictive power. This perspective highlights recent advances, ongoing challenges, and the need for multiscale modeling frameworks and standardized experimental datasets to systematically explore LNP design space and improve the efficacy of next-generation formulations.

Authors

Institutions

Publication Details

Journal
npj Drug Discovery.
Published
2025-09-01
DOI
https://doi.org/10.1038/s44386-025-00024-3
Citations
4
Primary Topic
Lipid Membrane Structure and Behavior
Type
article
Field-Weighted Citation Impact
3.22

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Challenges and opportunities in computational studies for lipid nanoparticle development

Scott P. Brown, Sean K. Bedingfield, Arezoo M. Ardekani, Severin T. Schneebeli et al.
4 citations
npj Drug Discovery.
Lipid Membrane Structure and Behavior
3.22
article

Challenges and opportunities in computational studies for lipid nanoparticle development

Scott P. Brown, Sean K. Bedingfield, Arezoo M. Ardekani, Severin T. Schneebeli, Younghoon Oh, Jianing Li, Kyle J. Colston
article en
4 citations

Abstract

Lipid nanoparticles (LNPs) are essential carriers for genetic medicines, yet optimizing their design remains challenging due to numerous parameters. Computational methods—including molecular dynamics (MD), computational fluid dynamics (CFD), and machine learning (ML)—offer molecular insights and predictive power. This perspective highlights recent advances, ongoing challenges, and the need for multiscale modeling frameworks and standardized experimental datasets to systematically explore LNP design space and improve the efficacy of next-generation formulations.

npj Drug Discovery.Vol. 2(1)
Eli Lilly (United States) (US), Purdue University West Lafayette (US)
Eli Lilly and Company
Openalex Percentile: Top 8%
Lipid Membrane Structure and Behavior
3.22
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Challenges and opportunities in computational studies for lipid nanoparticle development — Scott P. Brown, Sean K. Bedingfield, et al. · npj Drug Discovery. (2025) | TGRS Research Map | TGRS